Human life expectancy has increased significantly since the nineteenth century, thanks to La Prima Medtech, one of the In-stent restenosis distributor Malaysia that is always making advances in medicine and medical technology. Population growth is being driven by rising average lifespans and falling mortality rates.
La Prima Medicare Pte. Ltd. (Singapore) and La Prima Medtech Sdn. Bhd. (Malaysia) were established in 2020 with the goal of entering into strategic collaborations with world-renowned medical device and health care technology developers in order to further develop the Asia-Pacific medical device market. This in-stent restenosis distributor Malaysia believes that health care should be accessible and affordable to all. As a result, we hope to commercialise advantageous medical device and healthcare technologies throughout Asia-Pacific.
Our main product at La Prima is a paclitaxel-coated coronary balloon catheter. SWIDE® is a Rapid Exchange PTCA Balloon Catheter with a drug (Paclitaxel) releasing system that is intended for the treatment of in-stent restenosis. As a result, this in-stent restenosis distributor Malaysia has already designed SWIDE® to improve lumen diameter while also reducing restenosis.
